Thailand Pneumonia Vaccine Market (2026-2032) Outlook | Analysis, Value, Share, Forecast, Size, Revenue, Companies, Growth, Trends & Industry

Market Forecast By Vaccine Type (Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine), By Product Type (Prevnar 13, Synflorix, Pneumovax 23), By Sector (Public, Private), By Distribution Channel (Distribution Partner Companies, Non-governmental Organizations (NGO), Government Authorities) And Competitive Landscape
Product Code: ETC340825 Publication Date: Aug 2022 Updated Date: Jul 2026 Product Type: Market Research Report
Publisher: 6Wresearch Author: Ravi Bhandari No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Thailand Pneumonia Vaccine Market Size, Share & Growth Rate

The Thailand Pneumonia Vaccine Market was estimated at USD 133 Million in 2025 and is projected to reach USD 152 Million by 2032, growing at a CAGR of 1.9% from 2026 to 2032. This growth is primarily fueled by the Thai governments ongoing commitment to improving healthcare access and infrastructure, particularly in vaccination programs aimed at high-risk populations. The increasing prevalence of pneumonia, especially among the elderly, alongside rising public health awareness regarding preventive measures, contributes significantly to the market's upward trajectory.

Thailand Pneumonia Vaccine Market Year-wise Growth Rate and Key Drivers

This graph highlights how the Thailand Pneumonia Vaccine Market has steadily grown over the years, supported by major growth factors.

Thailand Pneumonia Vaccine Market Year-wise Growth Rate and Key Drivers

The table below presents the year‑wise growth rates along with the key drivers influencing the market

Year Growth Rate Major Drivers
2021 -3.5% decreased public health funding
2022 2.6% increased healthcare awareness campaigns
2023 3.2% growing demand for preventive care
2024 2.8% expansion of immunization programs
2025 3.4% rising investments in healthcare infrastructure
2026 3.1% improvement in healthcare accessibility
2027 2.3% enhanced collaboration among stakeholders
2028 2.4% growth in global health initiatives
2029 3.2% increased focus on infectious diseases
2030 2.7% development of new healthcare technologies
2031 3.1% expanding manufacturing base activity
2032 3.0% growing regional consumption patterns

Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.

Thailand Pneumonia Vaccine Market Synopsis

In Thailand, pneumonia vaccines are an essential part of routine immunization, targeting the most vulnerable segments of the population. With the focus on expanding healthcare accessibility, these vaccines are crucial in mitigating the morbidity and mortality rates associated with pneumonia.

The market encompasses a range of vaccine formulations, each developed to combat specific pneumonia-causing pathogens. Government initiatives aimed at increasing vaccination coverage, along with targeted public awareness campaigns, are vital in addressing the disease's burden across different demographics in Thailand.

Thailand Pneumonia Vaccine Market Key Takeaways

  • The market is driven by increasing healthcare expenditure and a focus on preventive health measures.
  • Public awareness campaigns significantly influence vaccination rates across various demographics.
  • Government partnerships with pharmaceutical companies enhance vaccine distribution and accessibility.
  • Rising air pollution and antibiotic resistance further highlight the need for effective pneumonia prevention strategies.
  • The COVID-19 pandemic has catalyzed a broader acceptance of vaccinations within Thai society.

Evaluation of Restraints in Thailand Pneumonia Vaccine Market

Despite its growth potential, the Thailand pneumonia vaccine market faces several significant restraints. Accessibility remains a critical challenge, as ensuring affordable and widespread availability of vaccines is essential for effective public health outcomes. Vaccine hesitancy, exacerbated by misinformation, poses hurdles to achieving desired immunization coverage rates. Moreover, the ongoing evolution of pneumonia pathogens necessitates continuous investment in research and development, putting pressure on resources and innovation within the industry.

Thailand Pneumonia Vaccine Market Trends

Current trends in the Thailand pneumonia vaccine market indicate a shift towards personalized vaccination approaches, with an emphasis on targeting specific age groups and risk factors. Additionally, technological advancements are leading to the development of more effective vaccine formulations. There is also a rising trend of integrating pneumonia vaccination into broader health campaigns, highlighting the importance of immunization in overall health and wellness strategies.

Thailand Pneumonia Vaccine Market Opportunities

The market presents multiple growth opportunities, particularly through government collaborations aimed at bolstering vaccine accessibility and affordability. Expanding the range of pneumococcal vaccines, especially those that address emerging strains of pathogens, can enhance public health efforts. Furthermore, increasing investment in public health infrastructure, spurred by the lessons learned during the COVID-19 pandemic, can improve distribution channels and ultimately drive up vaccination rates.

Government Initiatives in the Thailand Pneumonia Vaccine Market

The Thai government is actively investing in healthcare initiatives aimed at improving vaccination coverage for pneumonia. Policy measures include the integration of pneumonia vaccines into existing immunization programs and public health campaigns designed to raise awareness of respiratory illnesses. Enhanced funding for healthcare facilities and outreach programs is also being prioritized to ensure wider access to these critical vaccines, underscoring the nations commitment to combating pneumonia-related morbidity and mortality.

Future Insights of the Thailand Pneumonia Vaccine Market

As we look ahead to the period from 2026 to 2032, the Thailand pneumonia vaccine market is poised for continued growth, driven by demographic shifts and heightened health awareness. With an aging population, the emphasis on preventive healthcare is likely to intensify, leading to increased vaccination rates. Additionally, ongoing innovations in vaccine development and distribution strategies will be essential in responding to the dynamic landscape of pneumonia-causing pathogens, thus ensuring effective public health measures are in place.

Thailand Pneumonia Vaccine Market Latest Developments (2025 - 2026)

Recent developments in the Thailand pneumonia vaccine market have centered around strengthening partnerships between government entities and pharmaceutical companies to enhance distribution networks. Innovations in vaccine formulation are also being explored to address emerging strains of pneumonia pathogens. Additionally, increased public health campaigns aimed at educating citizens about the benefits of vaccination have seen positive responses, reflecting an evolving landscape in public health priorities.

Thailand Pneumonia Vaccine Market - Key Attractiveness of the Report

  • 10 Years of Market Numbers
  • Historical Data Starting from 2022 to 2025
  • Base Year: 2025
  • Forecast Data until 2032
  • Key Performance Indicators Impacting the Market
  • Major Upcoming Developments and Projects

Key Highlights of the Report:

  • Thailand Pneumonia Vaccine Market Outlook
  • Market Size of Thailand Pneumonia Vaccine Market, 2025
  • Forecast of Thailand Pneumonia Vaccine Market, 2032
  • Historical Data and Forecast of Thailand Pneumonia Vaccine Revenues & Volume for the Period 2022-2032F
  • Thailand Pneumonia Vaccine Market Trend Evolution
  • Thailand Pneumonia Vaccine Market Drivers and Challenges
  • Thailand Pneumonia Vaccine Price Trends
  • Thailand Pneumonia Vaccine Porter's Five Forces
  • Thailand Pneumonia Vaccine Industry Life Cycle
  • Historical Data and Forecast of Thailand Pneumonia Vaccine Market Revenues & Volume By Vaccine Type for the Period 2022-2032F
  • Historical Data and Forecast of Thailand Pneumonia Vaccine Market Revenues & Volume By Pneumococcal Conjugate Vaccine for the Period 2022-2032F
  • Historical Data and Forecast of Thailand Pneumonia Vaccine Market Revenues & Volume By Pneumococcal Polysaccharide Vaccine for the Period 2022-2032F
  • Historical Data and Forecast of Thailand Pneumonia Vaccine Market Revenues & Volume By Product Type for the Period 2022-2032F
  • Historical Data and Forecast of Thailand Pneumonia Vaccine Market Revenues & Volume By Prevnar 13 for the Period 2022-2032F
  • Historical Data and Forecast of Thailand Pneumonia Vaccine Market Revenues & Volume By Synflorix for the Period 2022-2032F
  • Historical Data and Forecast of Thailand Pneumonia Vaccine Market Revenues & Volume By Pneumovax 23 for the Period 2022-2032F
  • Historical Data and Forecast of Thailand Pneumonia Vaccine Market Revenues & Volume By Sector for the Period 2022-2032F
  • Historical Data and Forecast of Thailand Pneumonia Vaccine Market Revenues & Volume By Public for the Period 2022-2032F
  • Historical Data and Forecast of Thailand Pneumonia Vaccine Market Revenues & Volume By Private for the Period 2022-2032F
  • Historical Data and Forecast of Thailand Pneumonia Vaccine Market Revenues & Volume By Distribution Channel for the Period 2022-2032F
  • Historical Data and Forecast of Thailand Pneumonia Vaccine Market Revenues & Volume By Distribution Partner Companies for the Period 2022-2032F
  • Historical Data and Forecast of Thailand Pneumonia Vaccine Market Revenues & Volume By Non-governmental Organizations (NGO) for the Period 2022-2032F
  • Historical Data and Forecast of Thailand Pneumonia Vaccine Market Revenues & Volume By Government Authorities for the Period 2022-2032F
  • Thailand Pneumonia Vaccine Import Export Trade Statistics
  • Market Opportunity Assessment By Vaccine Type
  • Market Opportunity Assessment By Product Type
  • Market Opportunity Assessment By Sector
  • Market Opportunity Assessment By Distribution Channel
  • Thailand Pneumonia Vaccine Top Companies Market Share
  • Thailand Pneumonia Vaccine Competitive Benchmarking By Technical and Operational Parameters
  • Thailand Pneumonia Vaccine Company Profiles
  • Thailand Pneumonia Vaccine Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

The growth in the Thailand pneumonia vaccine market is primarily driven by government initiatives to enhance healthcare infrastructure and public awareness of vaccination's importance, particularly among the elderly and vulnerable populations.
The Thailand Pneumonia Vaccine Market was estimated at USD 133 Million in 2025 and is projected to reach USD 152 Million by 2032, growing at a CAGR of 1.9% from 2026 to 2032.
The COVID-19 pandemic initially disrupted routine immunization programs, including those for pneumonia. However, it also increased the emphasis on the importance of vaccines, potentially boosting future investments in vaccination programs.
Accessibility and affordability of vaccines remain significant challenges, as well as public hesitancy influenced by misinformation. Addressing these barriers is crucial for improving overall vaccination rates.
Government initiatives are vital in enhancing vaccine accessibility and affordability through funding, public health campaigns, and integration of pneumonia vaccines into routine immunization schedules.
6Wresearch actively monitors the Thailand Pneumonia Vaccine Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Thailand Pneumonia Vaccine Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Thailand Pneumonia Vaccine Market Overview

3.1 Thailand Country Macro Economic Indicators

3.2 Thailand Pneumonia Vaccine Market Revenues & Volume, 2022 & 2032F

3.3 Thailand Pneumonia Vaccine Market - Industry Life Cycle

3.4 Thailand Pneumonia Vaccine Market - Porter's Five Forces

3.5 Thailand Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2022 & 2032F

3.6 Thailand Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2022 & 2032F

3.7 Thailand Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2022 & 2032F

3.8 Thailand Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F

4 Thailand Pneumonia Vaccine Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about the importance of vaccination in Thailand

4.2.2 Growing government initiatives to promote vaccination programs

4.2.3 Rising prevalence of pneumonia cases in Thailand

4.3 Market Restraints

4.3.1 High cost of pneumonia vaccines

4.3.2 Limited access to healthcare services in remote areas of Thailand

4.3.3 Presence of alternative treatment options for pneumonia

5 Thailand Pneumonia Vaccine Market Trends

6 Thailand Pneumonia Vaccine Market, By Types

6.1 Thailand Pneumonia Vaccine Market, By Vaccine Type

6.1.1 Overview and Analysis

6.1.2 Thailand Pneumonia Vaccine Market Revenues & Volume, By Vaccine Type, 2022-2032F

6.1.3 Thailand Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2022-2032F

6.1.4 Thailand Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2022-2032F

6.2 Thailand Pneumonia Vaccine Market, By Product Type

6.2.1 Overview and Analysis

6.2.2 Thailand Pneumonia Vaccine Market Revenues & Volume, By Prevnar 13, 2022-2032F

6.2.3 Thailand Pneumonia Vaccine Market Revenues & Volume, By Synflorix, 2022-2032F

6.2.4 Thailand Pneumonia Vaccine Market Revenues & Volume, By Pneumovax 23, 2022-2032F

6.3 Thailand Pneumonia Vaccine Market, By Sector

6.3.1 Overview and Analysis

6.3.2 Thailand Pneumonia Vaccine Market Revenues & Volume, By Public, 2022-2032F

6.3.3 Thailand Pneumonia Vaccine Market Revenues & Volume, By Private, 2022-2032F

6.4 Thailand Pneumonia Vaccine Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 Thailand Pneumonia Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2022-2032F

6.4.3 Thailand Pneumonia Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2022-2032F

6.4.4 Thailand Pneumonia Vaccine Market Revenues & Volume, By Government Authorities, 2022-2032F

7 Thailand Pneumonia Vaccine Market Import-Export Trade Statistics

7.1 Thailand Pneumonia Vaccine Market Export to Major Countries

7.2 Thailand Pneumonia Vaccine Market Imports from Major Countries

8 Thailand Pneumonia Vaccine Market Key Performance Indicators

8.1 Immunization coverage rate for pneumonia vaccines in Thailand

8.2 Number of government-funded vaccination campaigns conducted annually

8.3 Percentage increase in demand for pneumonia vaccines in Thailand

8.4 Average waiting time for receiving pneumonia vaccination in healthcare facilities

8.5 Number of reported pneumonia cases in Thailand

9 Thailand Pneumonia Vaccine Market - Opportunity Assessment

9.1 Thailand Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2022 & 2032F

9.2 Thailand Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2022 & 2032F

9.3 Thailand Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2022 & 2032F

9.4 Thailand Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F

10 Thailand Pneumonia Vaccine Market - Competitive Landscape

10.1 Thailand Pneumonia Vaccine Market Revenue Share, By Companies, 2025

10.2 Thailand Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Leadership Perspectives from Industry Events

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Industry Events and Analyst Meet

Whitepaper

Read All